FDA clears influenza assay from InDevR

06:53 EDT 1 May 2019 | SmartBrief

The FDA has granted 510(k) clearance to InDevR's FluChip-8G Influenza A+B assay, which can be used to identify and differenti -More

Original Article: FDA clears influenza assay from InDevR


More From BioPortfolio on "FDA clears influenza assay from InDevR"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...

An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...